We are live on ! Find out more
NVLN

Novelion Therapeutics Inc. Common Shares
NVLN

Delisted

NVLN was delisted on the 8th of October, 2019.

35 hedge funds and large institutions have $5.35M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3535 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

38% less capital invested

Capital invested by funds: $8.63M → $5.35M (-$3.28M)

46% less call options, than puts

Call options by funds: $46K | Put options by funds: $85K

Holders
35
Holders Change
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
7
Reduced
9
Closed
5
Calls
$46K
Puts
$85K
Net Calls
-$39K
Net Calls Change
-$105K
Name Holding Trade Value Shares
Change
Change in
Stake
JAM
26
JW Asset Management
Florida
-$389K -315,979 Closed
AG
27
Artal Group
Luxembourg
-$315K -256,400 Closed
CCM
28
Context Capital Management
California
-$52 -42,534 Closed
JP Morgan Chase
29
JP Morgan Chase
New York
-$1.52K -1,364 -69%
Morgan Stanley
30
Morgan Stanley
New York
-$697 -627 -41%
TRCT
31
Tower Research Capital (TRC)
New York
-$1K -500 Closed
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
-$236 -212 -32%
LTFS
33
Ladenburg Thalmann Financial Services
Florida
-$68 -61 -34%
AG
34
Advisor Group
Arizona
+$111 +100 New